Small Proteins, Big Potential: New Approaches to Dementia & Cancer – Zurich
Save the date! Registration will open shortly!
How can tiny engineered proteins help medicines reach the brain, identify tumours and act precisely where they are needed most?
In partnership with Scandinavian Forum Switzerland, we’re inviting you to an evening at ETH Zürich exploring how protein engineering is creating new opportunities for the diagnosis and treatment of some of today’s most challenging diseases.
Professors Stefan Ståhl and John Löfblom from KTH Royal Institute of Technology will present their research on affibodies – small, highly stable engineered proteins that are approximately 4% of the size of monoclonal antibodies. Their compact structure enables excellent tissue penetration and precise targeting.
The lecture will explore affibody-based research in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia, including technologies designed to improve transport across the blood–brain barrier. It will also examine applications in cancer imaging and targeted treatment, where affibodies can guide radioisotopes or cytotoxic agents directly to tumour cells while potentially limiting effects on healthy tissue.
The evening will be hosted at ETH Zürich by Prof. Jörg Scheuermann and Prof. Dario Neri, who will provide a short introduction to ligand discovery and ligand-based drug delivery. The scientific programme will conclude with an open discussion, followed by a networking apéritif.
Intoduction Speakers
Prof. Dr. Dario Neri
Lecturer at the Department of Chemistry and Applied Biosciences, EHT Zurich
Prof. Dr. Jörg Scheuermann
Privatdozent am Departement Chemie und Angewandte Biowissenschaften, ETH
Speakers
Stefan Ståhl
Professor Molecular Biotechnology at KTH
John Löfblom
Associate Professor, Protein Technology at KTH
Programme
18:00–18:10 Welcome by SSCC & Scandinavian Forum Switzerland
18:10–18:20 Introduction to ETH activities by Jörg Scheuermann and Dario Neri
18:20–18:25 Introduction and laudatio of the guest lecturers Dario Neri
18:25–19:10 Guest lecture: affibody-based approaches to dementia and cancer Stefan Ståhl and John Löfblom
19:10–20:00 Discussion and Q&A
20:00-21:00 Networking Apéro
Fees
SSCC members: CHF TBD
Non-Members: CHF TBD
In collaboration with
Terms & Conditions
For event registrations our general policy is that refunds will only be issued for cancellations occurring 3 days or more prior to the event start date. For cancellations 1-2 days before a refund of 50% will be issued. In case of cancellations the same day or non-attendance (“no-show”) the entire participation fee will be charged. In case of no-show for events free of charge, the SSCC will charge a no-show fee of CHF 50.
Any variation from the above stated policy must be clearly indicated at the time the event registration occurs, and the policy above shall be deemed applicable in the absence of any other notification.
